FDA Expands Uzedy Indication to Bipolar I Disorder

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I disorder in adults.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-expands-uzedy-indication-bipolar-i-disorder-2025a1000rk1?src=rss

Author :

Publish date : 2025-10-13 16:48:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

FDA Expands Uzedy Indication to Bipolar I Disorder

AI in Sleep: Leveraging Wearables While Avoiding Legal Pitfalls

How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?

Related Posts

When It Comes to the Shingles Vaccine, More Is Better

Good Cancer Control, Survival With SBRT for Limited Metastatic/Progressive Disease

Radiation-Free Approach Promising for Some Locally Advanced Lung Cancers

HES Volume Expander Comes Back With Redeeming Safety Data

Alpha-Gal Syndrome: What to Know

Many Young Adults Use Cannabis or Booze as a Sleep Aid

When It Comes to the Shingles Vaccine, More Is Better

Good Cancer Control, Survival With SBRT for Limited Metastatic/Progressive Disease

Radiation-Free Approach Promising for Some Locally Advanced Lung Cancers

HES Volume Expander Comes Back With Redeeming Safety Data

Alpha-Gal Syndrome: What to Know

Many Young Adults Use Cannabis or Booze as a Sleep Aid

Prescription Drug Coverage Options Are Shrinking for Medicare Shoppers

FDA Adds Boxed Warning for IEC-EC to CAR-T Drug

Categories

Archives